Austex Pharmaceutical Private Limited, a active private limited company, was established on 26 September 2016 in Bally Jagachha, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909WB2016PTC217765. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Its leadership includes Sumit Kumar Singh (Director), Shalini Singh (Director). Past directors included Prince Kumar Singh, Jagjit Kumar Singh, Sumit Kumar Singh. It holds ₹3.57 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 16, Dr. A N Pal Lane, Jmt Enclave, Block-B, Ground Floor, Bally Jagachha, West Bengal, 711201.
U51909WB2016PTC217765
217765
26 September 2016
₹3.00 Cr
₹3.00 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Austex Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Kumar Singh | Director | 27 Sep 2021 | Current |
| Shalini Singh | Director | 18 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jul 2024 | Past |
| Pramod Abcsdd | Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 09 Aug 2024 | Past |
| Pramod Abcsdd | Director | 13 Oct 2016 | Past |
| Pramod Abcsdd | Director | 13 Jun 2018 | Past |
| Pramod Abcsdd | Director | 12 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Austex Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.76% increase. The company also saw a slight improvement in profitability, with a 2.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 61.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Austex Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹35,650,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2025 | Others | ₹1.57 Cr | Open |
| 31 Aug 2024 | Indian Overseas Bank | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Austex Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Austex Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Austex Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 1.57 Cr with Charge ID 101144446 was registered on 28 Aug 2025. was recorded as a recent event.
The activity Austex Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge with Indian Overseas Bank amounted to Rs. 2.00 Cr with Charge ID 100973588 was registered on 31 Aug 2024. was documented.
The activity Shalini Singh was appointed as a Director was appointed as a Director on 18 Jul 2024 & has been associated with this company since 1 year 4 months . was completed.
Progress on Austex Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
The activity Sumit Kumar Singh was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 2 months . was completed.
The CIN of Austex Pharmaceutical Private Limited is U51909WB2016PTC217765.
Austex Pharmaceutical Private Limited is headquartered at 16, Dr. A N Pal Lane, Jmt Enclave, Block-B, Ground Floor, Bally Jagachha, West Bengal, 711201.
Austex Pharmaceutical Private Limited was incorporated on 26 September 2016.
The current directors of Austex Pharmaceutical Private Limited are
The primary industry of Austex Pharmaceutical Private Limited is Manufacturing.
Austex Pharmaceutical Private Limited is unlisted.
The authorized capital of Austex Pharmaceutical Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Austex Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX